Premier Hospice, Llc 1513 Texas Avenue, Bastrop, LA, 71220 | |
(318) 556-1999 |
News Archive
What if a single smartphone app could help solve the enigma of multiple sclerosis and move new treatments ahead at lightning speed? That was the bold idea that led Keck Medicine of USC neurologist Daniel Pelletier, MD, professor of neurology at the Keck School of Medicine of USC and division chief of the Neuro-Immunology and USC Multiple Sclerosis Center, to develop myMS, the world's first smartphone app capable of collecting large amounts of clinical, imaging and genetic data for people with MS. Enrollment is now underway for a pilot study of the app.
NIH-supported researchers at Massachusetts General Hospital are studying an alternative to the contrast agents currently used for magnetic resonance imaging.
Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
A new strategy to reduce the side effects suffered by patients undergoing treatment for head and neck cancers now has the support of the National Institutes of Health.
Part of the fun of Halloween is being afraid – very afraid – but, it turns out at least one of our top fears is unfounded.
› Verified 7 days ago
Name | Premier Hospice, Llc |
---|---|
Location | 1513 Texas Avenue, Bastrop, Louisiana |
Hospice ID | 191615 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Other |
Profit Type | FOR PROFIT |
SSA county code | 330 |
News Archive
What if a single smartphone app could help solve the enigma of multiple sclerosis and move new treatments ahead at lightning speed? That was the bold idea that led Keck Medicine of USC neurologist Daniel Pelletier, MD, professor of neurology at the Keck School of Medicine of USC and division chief of the Neuro-Immunology and USC Multiple Sclerosis Center, to develop myMS, the world's first smartphone app capable of collecting large amounts of clinical, imaging and genetic data for people with MS. Enrollment is now underway for a pilot study of the app.
NIH-supported researchers at Massachusetts General Hospital are studying an alternative to the contrast agents currently used for magnetic resonance imaging.
Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
A new strategy to reduce the side effects suffered by patients undergoing treatment for head and neck cancers now has the support of the National Institutes of Health.
Part of the fun of Halloween is being afraid – very afraid – but, it turns out at least one of our top fears is unfounded.
› Verified 7 days ago
NPI Number | 1720011588 |
Organization Name | Premier Hospice, Llc |
Address | 1513 Texas Ave Bastrop, Louisiana, 71220 |
Phone Number | (318)556-1999 |
News Archive
What if a single smartphone app could help solve the enigma of multiple sclerosis and move new treatments ahead at lightning speed? That was the bold idea that led Keck Medicine of USC neurologist Daniel Pelletier, MD, professor of neurology at the Keck School of Medicine of USC and division chief of the Neuro-Immunology and USC Multiple Sclerosis Center, to develop myMS, the world's first smartphone app capable of collecting large amounts of clinical, imaging and genetic data for people with MS. Enrollment is now underway for a pilot study of the app.
NIH-supported researchers at Massachusetts General Hospital are studying an alternative to the contrast agents currently used for magnetic resonance imaging.
Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
A new strategy to reduce the side effects suffered by patients undergoing treatment for head and neck cancers now has the support of the National Institutes of Health.
Part of the fun of Halloween is being afraid – very afraid – but, it turns out at least one of our top fears is unfounded.
› Verified 7 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 99.5 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 85.4 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
What if a single smartphone app could help solve the enigma of multiple sclerosis and move new treatments ahead at lightning speed? That was the bold idea that led Keck Medicine of USC neurologist Daniel Pelletier, MD, professor of neurology at the Keck School of Medicine of USC and division chief of the Neuro-Immunology and USC Multiple Sclerosis Center, to develop myMS, the world's first smartphone app capable of collecting large amounts of clinical, imaging and genetic data for people with MS. Enrollment is now underway for a pilot study of the app.
NIH-supported researchers at Massachusetts General Hospital are studying an alternative to the contrast agents currently used for magnetic resonance imaging.
Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
A new strategy to reduce the side effects suffered by patients undergoing treatment for head and neck cancers now has the support of the National Institutes of Health.
Part of the fun of Halloween is being afraid – very afraid – but, it turns out at least one of our top fears is unfounded.
› Verified 7 days ago
Home Health Aides | 6 |
Counselors | 3 |
Licensed Practical or Vocational Nurses | 3 |
Medical Social Workers | 1 |
Registered Nurses | 4 |
Total Employees | 17 |
---|
News Archive
What if a single smartphone app could help solve the enigma of multiple sclerosis and move new treatments ahead at lightning speed? That was the bold idea that led Keck Medicine of USC neurologist Daniel Pelletier, MD, professor of neurology at the Keck School of Medicine of USC and division chief of the Neuro-Immunology and USC Multiple Sclerosis Center, to develop myMS, the world's first smartphone app capable of collecting large amounts of clinical, imaging and genetic data for people with MS. Enrollment is now underway for a pilot study of the app.
NIH-supported researchers at Massachusetts General Hospital are studying an alternative to the contrast agents currently used for magnetic resonance imaging.
Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
A new strategy to reduce the side effects suffered by patients undergoing treatment for head and neck cancers now has the support of the National Institutes of Health.
Part of the fun of Halloween is being afraid – very afraid – but, it turns out at least one of our top fears is unfounded.
› Verified 7 days ago
Others | 5 |
Total Volunteers | 5 |
---|
News Archive
What if a single smartphone app could help solve the enigma of multiple sclerosis and move new treatments ahead at lightning speed? That was the bold idea that led Keck Medicine of USC neurologist Daniel Pelletier, MD, professor of neurology at the Keck School of Medicine of USC and division chief of the Neuro-Immunology and USC Multiple Sclerosis Center, to develop myMS, the world's first smartphone app capable of collecting large amounts of clinical, imaging and genetic data for people with MS. Enrollment is now underway for a pilot study of the app.
NIH-supported researchers at Massachusetts General Hospital are studying an alternative to the contrast agents currently used for magnetic resonance imaging.
Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
A new strategy to reduce the side effects suffered by patients undergoing treatment for head and neck cancers now has the support of the National Institutes of Health.
Part of the fun of Halloween is being afraid – very afraid – but, it turns out at least one of our top fears is unfounded.
› Verified 7 days ago
Premier Hospice, Llc Location: 1513 Texas Avenue, Bastrop, Louisiana, 71220 Phone: (318) 556-1999 |